Literature DB >> 4906024

[Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].

E F Pfeiffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4906024

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN： 0001-5563


× No keyword cloud information.
  6 in total

1.  [Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].

Authors:  K Schöffling; E Haupt; W Köberich; J Beyer
Journal:  Klin Wochenschr       Date:  1973-01-15

2.  Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.

Authors:  P Berchtold; P Björntorp; A Gustafson; A Jonsson; S E Fagerberg
Journal:  Eur J Clin Pharmacol       Date:  1971-12       Impact factor: 2.953

3.  Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test.

Authors:  E F Pfeiffer; S Raptis
Journal:  Diabetologia       Date:  1972-02       Impact factor: 10.122

4.  Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.

Authors:  E Haupt; W Köberich; J Beyer; K Schöffling
Journal:  Diabetologia       Date:  1971-12       Impact factor: 10.122

5.  Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.

Authors:  E Haupt; W Köberich; J Beyer; K Schöffling
Journal:  Diabetologia       Date:  1971-12       Impact factor: 10.122

Review 6.  The management of diabetes mellitus in older individuals.

Authors:  J E Morley; H M Perry
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.